A comprehensive view of Epidemic / Pandemic. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna announces Phase 3 success of next-gen COVID-19 vaccine, forthcoming flu combo vaccine, and progress in pivotal viral caccines set for 2024

Moderna initiates final phase of trials for four vaccines against latent infections, including chickenpox and shingles, and norovirus responsible for gastroenteritis; the company also developing a new-generation COVID-19 vaccine

US restaurant traffic sees 1% year-over-year growth in 2023, and the industry now stands at US$500B, with dollars exceeding 2019 levels by 12%, despite traffic remaining 8% below pre-pandemic levels: Circana

Moderna's next-generation COVID-19 vaccine, mRNA-1283, shows a higher immune response against SARS-CoV-2 in Phase 3 trial compared to the company's currently vaccine; the new vaccine also has potential for longer shelf life and storage benefits

BioNTech receives a notice of default from the NIH over allegedly owed vaccine royalties under a prior licensing agreement

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count